{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:05:30Z","timestamp":1773281130503,"version":"3.50.1"},"reference-count":22,"publisher":"Asia Pacific Academy of Ophthalmology","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia Pac J Ophthalmol (Phila)"],"published-print":{"date-parts":[[2019]]},"DOI":"10.22608\/apo.2018299","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T03:47:42Z","timestamp":1533008862000},"source":"Crossref","is-referenced-by-count":5,"title":["Neuroprotection in Optic Neuropathy"],"prefix":"10.22608","member":"9895","published-online":{"date-parts":[[2019]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","unstructured":"1. Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295\u20131304.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","unstructured":"2. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268\u20131279.","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.","volume":"120","author":"Kass","year":"2002","unstructured":"3. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701\u2013713; discussion 829\u2013830.","journal-title":"Arch Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9950","issn-type":"print"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00062-014-0304-8","article-title":"Magnetic resonance findings in chiasmal and pregeniculate ischemic neuropathy","volume":"25","author":"Demaerel","year":"2015","unstructured":"4. Demaerel P, Van Den Eynde K, Casteels I. Magnetic resonance findings in chiasmal and pregeniculate ischemic neuropathy. Clin Neuroradiol. 2015;25:193\u2013195.","journal-title":"Clin Neuroradiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0002-9394(14)73478-6","article-title":"Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy","volume":"116","author":"Burde","year":"1993","unstructured":"5. Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1993;116:759\u2013764.","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0161-6420(03)00804-2","article-title":"The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy","volume":"110","author":"Tesser","year":"2003","unstructured":"6. Tesser RA, Niendorf ER, Levin LA. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2003;110:2031\u20132035.","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/archopht.126.11.1582","article-title":"Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy","volume":"126","author":"Levin","year":"2008","unstructured":"7. Levin LA, Danesh-Meyer HV. Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008;126:1582\u20131585.","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0002-9394(14)70536-7","article-title":"Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months' duration","volume":"121","author":"Johnson","year":"1996","unstructured":"8. Johnson LN, Gould TJ, Krohel GB. Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months' duration. Am J Ophthalmol. 1996;121:77\u201383.","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0161-6420(99)00133-5","article-title":"Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy","volume":"107","author":"Johnson","year":"2000","unstructured":"9. Johnson LN, Guy ME, Krohel GB, et al. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107:521\u2013526.","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0161-6420(00)00301-8","article-title":"Does levodopa improve visual function in NAION?","volume":"107","author":"Beck","year":"2000","unstructured":"10. Beck RW, Ferris FL. Does levodopa improve visual function in NAION? Ophthalmology. 2000;107:1431\u20131434.","journal-title":"Ophthalmology","ISSN":"https:\/\/id.crossref.org\/issn\/0161-6420","issn-type":"print"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00417-005-0102-8","article-title":"2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial","volume":"244","author":"Wilhelm","year":"2006","unstructured":"11. Wilhelm B, Ludtke H, Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol. 2006;244:551\u2013558.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/jama.1995.03520320035038","article-title":"Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful.","volume":"273","year":"1995","unstructured":"12. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273:625\u2013632.","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0002-9394(02)01825-1","article-title":"A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol","volume":"135","author":"Beck","year":"2003","unstructured":"13. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003;135:194\u2013205.","journal-title":"Am J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","unstructured":"14. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963\u2013969.","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neuroimage.2005.11.051","article-title":"Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy","volume":"31","author":"Trip","year":"2006","unstructured":"15. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006;31:286\u2013293.","journal-title":"Neuroimage"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","unstructured":"16. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992;326:581\u2013588.","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ana.23573","article-title":"A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis","volume":"72","author":"Suhs","year":"2012","unstructured":"17. Suhs KW, Hein K, Sattler MB, et al. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol. 2012;72:199\u2013210.","journal-title":"Ann Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","article-title":"Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Raftopoulos","year":"2016","unstructured":"18. Raftopoulos R, Hickman SJ, Toosy A, et al. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15:259\u2013269.","journal-title":"Lancet Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","unstructured":"19. Cadavid D, Balcer L, Galetta S, et al. Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16:189\u2013199.","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","unstructured":"20. Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain. 2011;134:2677\u20132686.","journal-title":"Brain"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber's hereditary optic neuropathy.","volume":"134","author":"Carelli","year":"2011","unstructured":"21. Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber's hereditary optic neuropathy. Brain. 2011;134:e188.","journal-title":"Brain","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8950","issn-type":"print"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ajo.2005.03.058","article-title":"Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite","volume":"140","author":"Newman","year":"2005","unstructured":"22. Newman NJ, Biousse V, David R, et al. Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol. 2005;140:407\u2013415.","journal-title":"Am J Ophthalmol"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T20:07:47Z","timestamp":1561752467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/apjoo\/Fulltext\/2018\/07000\/Neuroprotection_in_Optic_Neuropathy.6.aspx"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"URL":"https:\/\/doi.org\/10.22608\/apo.2018299","relation":{},"ISSN":["2162-0989","2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"},{"value":"2162-0989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}